Acorn Capital Advisors »

Candel Therapeutics shares owned by Acorn Capital Advisors

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Acorn Capital Advisors from 13F filings

Historical chart of Acorn Capital Advisors investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Acorn Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Acorn Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $13M 2.6M 5.10
2025-06-30 $13M 2.6M 5.06
2025-03-31 $12M 2.2M 5.65
2024-12-31 $17M 1.9M 8.68